The 505 amino acid L1 protein of the human papillomavirus type 11 (HPV 11) is the major capsid polypeptide that has been shown to self-assemble into virus-like particles (VLPs) in vivo and in vitro. While L1 is essential for viral infection, expression studies in mammalian cells have been hampered by different codon preference between the virus and its host. To optimize L1 gene expression in mammalian cells, we converted wild-type HPV 11 L1 (11 L1wt) codons to those more common in human genes. The modified HPV 11 L1 gene (11 L1h) generated protein levels that were at least 100-fold higher than those of wild-type HPV 11 L1, while no obvious differences were seen in the level of mRNA. HPV 11 L1 protein was detected in mammalian epithelial and fibroblast cells, by immunoblotting and indirect immunofluorescence (IIF) techniques. Unlike the situation in situ, IIF revealed the presence of L1 mainly at perinuclear sites. Virus-like particles assembled intranuclearly only to a low extent, as indicated by transmission electron microscopy. DNA vaccination using the HPV 11 L1h gene yielded a drastic increase in L1-specific antibody production in mice as compared to immunization with the wild-type gene.
Introduction
Human papillomaviruses are small double-stranded DNA viruses that are the causative agents of warts and have also been associated with certain cancers in a variety of animal hosts. High-risk human papillomaviruses, such as HPV type 16 and 18 play a critical role in the development of cervical intraepithelial neoplasia and invasive cervical cancer (zur Hausen, 1996) . In contrast, the low-risk HPV types 6 and 11 are rarely associated with the progression of malignancies, but they are responsible for benign genital warts, i.e., condylomata acuminata, the most common sexually transmitted viral disease (Gissmann et al., 1983; Koutsky et al., 1988) . Moreover, they are involved in recurrent respiratory papillomatosis (RRP), a rare but serious condition, characterized by recurrent wart formation within the aerodigestive tract (Gabbott et al., 1997; Gelder et al., 2003; Lele et al., 2002) . Considerable information is available concerning the pathogenesis of high-risk HPV types, but little is known about the virus life cycle, in particular of the low-risk HPV types.
Studies of the replication of papillomaviruses have been hampered by the lack of a convenient cell culture system. The tight regulation of late gene expression is linked to the differentiation status of the infected host cell. In stratified epithelia, the expression of HPV 11 and HPV 16 capsid genes is confined to the differentiated cell layers, as demonstrated in cultures of epithelial tissue (Flores et al., 1999; Stoler et al., 1990) . In vivo, this expression pattern is believed to contribute to the immune evasion of the virus (O'Brien and Saveria Campo, 2002) . Among the mechanisms proposed for the regulation of papillomavirus late gene expression are (i) the presence of inhibitory elements located on the late gene mRNAs, as demonstrated for HPV 16 L1 (Collier et al., 2002) , and (ii) significant bias in codon usage between the viral and the mammalian genes (Zhou et al., 1999) . For several HPV genes, i.e., E5, E7, and L1 of HPV 16, in vitro studies have shown that codon adaptation to human cells results in an enhanced expression in these cells (Cid-Arregui et al., 2003; Disbrow et al., 2003; Leder et al., 2001) .
In the viral life cycle, the capsid proteins L1 and L2 form the icosahedral capsid that packages the viral genomic DNA within the nucleus (Zhou et al., 1995) . Under in vitro conditions, L1 alone or in conjunction with L2 is capable to self-assemble into virus-like particles (VLPs) as demonstrated by heterologous expression (Chen et al., 2001; Hagensee et al., 1993; Kirnbauer et al., 1992; Neeper et al., 1996; Rose et al., 1993) . These VLPs resemble infectious virions, thus becoming a promising tool for studies on certain aspects of the early papillomaviruses life cycle such as binding and uptake (Volpers et al., 1995) . Unlike the established systems, e.g., recombinant baculovirus (Le Cann et al., 1994; Rose et al., 1993) , the employment of a mammalian expression system facilitates the production of the L1 protein and the assembly of virus particles similar to the in vivo conditions. In addition, expression in mammalian cells allows studying the effects of late gene expression on the host cell.
In this study, we aimed to generate an HPV 11 L1 gene that, upon transfection into mammalian cells, produces significant amounts of protein. To this end, we modified the codon composition of the HPV 11 major capsid gene L1 by substituting all rarely used codons by those more frequently found in human genes. Use of the newly engineered gene (11 L1h) demonstrated that the substitution of the codons led to a significant increase of protein expression and resulted in the production of VLPs in mammalian cells. Furthermore, the codon-optimized 11L1h gene induces a strong immune response when compared to the nonmodified sequence, as has been previously reported for major capsid genes of other papillomavirus types, e.g., HPV 16 L1 and HPV 6b L1 (Leder et al., 2001; Liu et al., 2001b) .
Results

Construction of codon-modified HPV 11 L1 gene (11 L1h)
To increase the expression level of the HPV 11 major capsid protein L1 in mammalian cells, we replaced all codons by those more frequently used in mammalian genes without modifying the protein sequence (Codon Usage Database Kazusa, Table 1 ). The 11 L1h was generated from synthetic oligonucleotides by fusion-PCR, and cloned into a mammalian expression vector containing the human cytomegalovirus immediate -early promoter (pCMV). Inhibitory sequences were described within AU-rich coding regions of the HPV 16 L1 mRNA (Tan et al., 1995) . We assumed that the higher GC content (about 1.5-fold; Table 1 ) generated by the codon optimization of the HPV 11 L1 sequence would inactivate the putative negative regulatory elements within the wild-type L1 open reading frame and, thus, further increases the expression level of the 11 L1h gene transfected into mammalian cells. The complete codon-optimized 11 L1h sequence used in the current study is deposited with GenBank under accession number AY541029.
Expression of 11 L1wt and 11 L1h after transfection in mammalian cells
To analyze the efficiency of the L1 constructs, the 11 L1h and the 11 L1wt ORF placed under the control of the CMV immediate early promoter were transiently transfected into mammalian cells (Cos-1, 293T, and CHO-09). To control for transfection efficiencies of the individual L1 expression vectors, we cotransfected a plasmid expressing the EGFRgene. As shown in Fig. 1a for human 293T cells, the expression of the L1 protein by 11 L1h was significantly higher. Considering the level of EGFR (about 1.5 times lower in the 11 L1h than in the 11 L1wt transfected cells; Fig. 2a) , we estimated the difference to be at least 100-fold (Fig. 1a) . This approximation seems to be underestimated, because the 11 L1wt protein could not be detected at all.
We further investigated whether the higher protein expression by the 11 L1h gene was based on enhanced translation of its mRNA. To this end, we performed realtime quantitative RT-PCR to determine the level of 11 L1h mRNA and the corresponding 11 L1wt transcript within the transfected cells. The level of L1-specific mRNA was normalized to the neomycin transcript derived from the same vector, thus allowing a quantitative comparison of the expression of the 11 L1h and 11 L1wt plasmids (Fig.  1b) . In contrast to the protein expression results, the mRNA level of 11 L1h mRNA was about twofold lower than 11 L1wt mRNA, indicating that the L1 gene expression is posttranscriptionally regulated.
Localization of 11 L1h in mammalian cells
The increase in expression level of the 11 L1h gene was corroborated by immunofluorescence techniques in Cos-1 cells. Expression of the L1 protein was examined 48 h after transfection. While transient transfection of 11 L1wt did not lead to any detectable fluorescence above the level of mock-transfected cells, the codon-optimized gene yielded a strong signal.
The high expression of the 11 L1h gene allowed us to analyze its subcellular localization in the transfected cells. Both in Cos-1 and in CHO-09 cells, the L1 protein appeared to be predominantly perinuclear with extension into the cytoplasm when examined by confocal laser scanning microscopy. Bright field microscopy revealed an intact nucleus ( Fig. 2a) and fluorescence demonstrated the major proportion of 11 L1h being localized around the nucleus (Fig. 2b ). This was confirmed by superimposing the bright field and the fluorescence (Fig. 2c) , and visualized in more detail by set stacks. The nucleus was mainly devoid of fluorescence, while L1-specific fluorescence was clearly detectable in the cytoplasm and at perinuclear sites ( Fig. 2d ) demonstrating the accumulation of 11 L1h in this region. This phenomenon was also observed in CHO-09 cells, where the majority of L1-transfected cells show predominantly L1 being localized around the nuclei (Figs. 2e -g ).
To further investigate the subcellular localization of the HPV 11 L1 protein, we fractionated the cellular proteins by Fig. 1 . Expression of wild-type HPV 11 and codon-optimized HPV 11 L1 on the protein and mRNA level. (a) Increased L1 protein levels detected by immunoblotting. Human 293T cells were transfected with 10 Ag of empty vector (pcDNA3.1), wild-type L1 (pcDNA3.1-11 L1wt), or codonoptimized L1 (pcDNA3.1-11 L1h) plasmid. Fifty micrograms of total protein were separated by PAGE. L1 was detected by HPV 11 L1-specific mAb. The level of 11 L1h compared with wild-type HPV 11 L1wt was around 100-fold higher. A representative blot is shown. (b) Total RNA was isolated from transfected 293T and subjected to quantitative RT-PCR to determine levels of L1 mRNA. The relative level of L1 RNA expression was normalized to the level of neomycin RNA expression. subcellular proteome extraction into a cytosolic, membranous, nuclear, and cytoskeletal fraction. The respective use of a calnexin (membrane protein) and a histone H1 (nuclear protein) antibody confirmed the proper separation into above-mentioned distinct fractions. Interestingly, immunoblotting demonstrated the presence of HPV 11 L1 protein in all fractions albeit at higher concentration in the nuclear and cytoskeletal, than in the membranous or the cytosolic, fractions (Fig. 3) . It is noteworthy that the high level of 11 L1 in the nuclear fraction does not necessarily indicate the presence of this protein within the nucleus, but is more likely a consequence of its binding to the nuclear membrane copurified with the nuclear fraction ( Fig. 3 ; see fluorescence data in Fig. 2c ). We hypothesize that the high abundance of the L1 protein in the cytoskeletal fraction is due to an association with microtubules as it has been shown for BPV-1 L1 by coimmunoprecipitation experiments with L1 and tubulin (Liu et al., 2001a (Liu et al., , 2001b ).
Assembly of virus-like particles (VLPs)
Next, we analyzed whether the increase in protein expression of 11 L1h leads to the formation of VLPs in mammalian cells. We transfected 293T cells with the 11 L1h plasmid and examined ultrathin sections by transmission electron microscopy. As shown in Fig. 4 , structures clearly resembling virus capsids were found within the nucleus. This finding has been corroborated by sucrose gradient centrifugation of extracts of transfected cells. In lysates, positive signals for the HPV 11 L1 protein were detected (by Western blot analysis) in the same fractions as VLPs produced in Sf9 insect cells (data not shown). As comparison, we repeated transfection experiments performed earlier with HPV 16 (Leder et al., 2001 ). The amount of VLPs detected by EM was lower for HPV 11 as in case of HPV 16.
DNA immunization of mice with L1h-expressing plasmids
To analyze the ability of the codon-optimized 11 L1 gene to form VLPs in vivo, we tested for the induction of an HPV 11 L1-specific humoral immune response in mice. Four animal per group were injected twice intramuscularly at 2-week intervals with either PBS, empty vector, or plasmid DNA expressing 11 L1wt or 11 L1h, respectively. Sera obtained 6 weeks after the first immunization were tested by an L1-specific ELISA. Significant antibody titers were elicited following injection of the 11 L1h plasmid, whereas the response after immunization with the wild-type L1 gene was only at background level (Fig. 5) . While cross-reactivity of HPV 11 L1 antibodies with the closely related HPV 6b L1 was detected (Fig. 5) , no binding to HPV 16 L1 was observed.
Discussion
A major obstacle in cultivating HPV virions in vitro is the tight linkage of replication to differentiating epithelia. While expression of early genes can be observed throughout a stratified epithelium, transcription of late genes occurs only in suprabasal cells. One determinant of the low expression level of papillomavirus (PV) genes in mammalian cells seems to be their codon composition that differs significantly from mammalian genes. In a study on the BPV-1 major capsid L1 protein, addition of the matched aminoacyl-tRNAs enhanced its expression in in vitro translation experiments (Zhou et al., 1999) .
Our objective was to design a synthetic HPV 11 L1 gene that expresses the viral structural protein in a high amount in mammalian cells. Altering the codon composition of the wild-type HPV 11 L1 gene into a typical mammalian sequence was expected to overcome the low expression levels. In fact, Western blot analysis and indirect immuno- Fig. 3 . Subcellular proteome extraction of 11 L1h-transfected cells 293T cells were transfected with 10 Ag of the 11 L1h expression plasmid. The cell lysate was separated into cytosolic, membranous, nuclear, and cytoskeletal fractions. One percent of the protein content of each fraction was loaded onto a SDS-PAGE, immunoblotted, and incubated with an anti-L1-specific antibody. Calnexin and histone H1 were used as controls for proper separation. Fig. 2 . Immunolocalization of HPV 11 L1 protein in Cos-1 and CHO-09 cells detected by indirect immunofluorescence (IIF). Cos-1 cells were transfected with empty vector (pcDNA3.1/mock), wild-type L1 (pcDNA3.1-11 L1wt), or codon-optimized L1 (pcDNA3.1-11 L1h) plasmid. CHO-09 cells were transfected with the optimized Flag-tagged L1 (pCMV2-Flag-11L1h) plasmid. For IIF, cells were stained with either CamVir L1-specific mab (Cos-1), or with the polyclonal anti-Flag antibody (CHO-09), followed by detection with a fluorochrome-coupled secondary antibody. Confocal laser scan microscopy revealed the absence of HPV 11 L1 expression in mock-and HPV 11 L1wt-transfected cells, while a strong perinuclear fluorescence indicated L1 expression originating from the codon-optimized HPV 11 L1h gene. (a) bright field image of (b); (c) superimposition of (a and b). The perinuclear localization of L1 was corroborated by set stack analysis (d). In CHO-09 cells, the L1 protein (green) was found to be mainly localized at perinuclear sites (e). Cell nuclei were counterstained with propidium iodide (red, f ). (g) Superimposition of (e and f ).
fluorescence (IIF) revealed that the codon optimization of the HPV 11 L1 gene leads at least to a 100-fold increase in protein expression when compared to the HPV 11 L1wt gene.
Since the amino acid sequence of both the codonoptimized and the wild-type gene is identical, the higher levels are likely not the consequence of altered protein stability. This conclusion is supported by earlier findings on the HPV 16 E7 protein whose half-life was reported to be identical independent on composition (wt or modified) of the coding gene (Cid-Arregui et al., 2003) . Analysis of the newly synthesized 11 L1h transcription using quantitative real-time PCR revealed that the level of mRNA was even lower when compared to 11 L1wt mRNA. Thus, the reasons for the difference in the amount of synthesized protein are so far unknown, but analysis of the Kozak sequence in the optimized and wt mRNA suggests that the changes caused by optimization are not responsible for the enhanced L1 translation (Wingender et al., 2002) .
We took advantage of the high level of the L1 gene expression to study its localization in mammalian cells in culture. Because DNA replication takes place inside the nucleus, nuclear import of the viral capsid proteins L1 and L2 is required for packaging of the viral DNA. Our data obtained by IIF laser confocal microscopy revealed a strong L1-specific perinuclear staining within the transfected cells, while only small amount of L1 protein was detected inside the nucleus. This is in contrast to previous reports where HPV 1 L1 or 16 L1 protein was mainly found in the nucleus (Ghim et al., 1992; Leder et al., 2001) . It is conceivable that the high abundance of the L1 protein expressed from the modified gene led to the formation of protein aggregates in the cytoplasm that are excluded from the passage through the nuclear pores. To further clarify the phenomenon of nuclear import, additional experiments in different mammalian cell types are in progress.
Previous reports on the heterologous expression of the L1 gene of different papillomaviruses including HPV 6, 11, and 16 in E. coli, yeast, or insect cells have demonstrated that the L1 protein has the ability to self-assemble into viral particles, with similar structural and immunological features to native empty virions (Chen et al., 2001; Hagensee et al., 1993; Kirnbauer et al., 1992; Neeper et al., 1996; Rose et al., 1993) . In this study, we clearly proved the presence of VLPs in mammalian cells, albeit at a lower extent when compared to cells transfected with the codon-optimized HPV 16 L1 gene (Leder et al., 2001) . This is in accordance with our IIF results displaying a limited import of the L1 protein into the nucleus. Nevertheless, the modified 11 L1 gene led to the expression of L1 protein, properly folded into VLP-like structures in mammalian cell and thus represents an experimental system for future studies on the effect of papillomavirus late gene expression in host cells. Our data on higher protein expression level using the 11 L1h gene and on the formation of VLPs were confirmed by immunization experiments yielding a high titer of antisera specific for HPV 11 VLPs (Fig. 5) .
Another aspect regarding the generation of the 11 L1h gene is the application as DNA vaccine. The psychological impact for the patient of suffering from genital warts Fig. 5 . HPV 11 L1-specific antibodies detected in the sera of mice following DNA immunization. Mice were immunized either with plasmid expressing HPV 11 L1h (black bars), HPV 11 L1wt (light gray bars) expression plasmid or with PBS (dark gray bars). Six weeks after the first immunization, mice were sacrificed and sera were diluted 1:50, and analyzed for L1-specific antibodies by a GST-capture ELISA. Each bar represents the mean absorbance (FSD) of all four mice per group. The sera were tested against HPV 11 L1, -6b L1, -16 L1 GST-tag proteins or for background reduction against GST-tag alone. Mice immunized with empty vector showed antibody titers similar to antibody response in control mice (PBS; data not shown). is often quite severe, although they rarely have the propensity for malignant transformation. Treatment of this common sexually transmitted disease consists primarily of ablation or removal of infected tissues and often results in painful, extensive, slow-healing ulcerations and frequent early relapse, although antiviral and immunomodulatory drugs have also been shown to have some therapeutic benefit (Gross, 2001; Maw and von Krogh, 2000; Moore et al., 2001) . Further, for HPV-11-induced recurrent respiratory papillomatosis, none of the existing medical treatment has been universally successful as well so far, so that surgical removal is inevitable (Williams et al., 2002) .
Thus, the development of HPV vaccines to prevent the effects of both high-risk and low-risk HPV infection is doubtlessly of great value. Besides HPV protein-based vaccines as VLPs, DNA vaccines, which are simple to produce, less expensive, and heat-stable, are under investigation. They encode for antigenic molecules that are produced and presented in a natural way by in vivo transfected cells. In contrast to HPV VLP-based vaccines, they provide the possibility for the construction of multivalent genes (i.e. HPV-6 L1, HPV 11 L1, and HPV 16 L1), thus contributing to a broader range of immunogenicity.
In our study, we demonstrated that vaccination with the 11 L1h gene induced an HPV 11 L1-specific humoral immune response, whereas no significant amount of L1-specific antibodies was obtained in the wild-type L1-immunized mice. Similar results were previously obtained with other codon-optimized papillomavirus major capsid genes such as HPV 16 L1 and HPV 6b L1 (Leder et al., 2001; Liu et al., 2001b) . The specificity of the HPV 11 L1 antibodies derived after immunization was tested by exposing the antibodies against the HPV 6b and 16 L1 proteins, respectively. While no reaction was seen in case of HPV 16, binding of the HPV 11 L1 antibodies to HPV 6b L1 was observed indicating a cross reactivity of the sera related to the high degree of homology in the amino acid sequence of the two L1 capsid proteins.
In summary, our results demonstrate that HPV 11 L1 gene expression might be subjected to tight regulation in mammalian cells because of existent differences in codon usage. This phenomenon might be a factor of HPV survival strategy, because low amounts of viral proteins could prevent the induction of the immune system, thus facilitating persistent infection. The codon-optimized major capsid protein L1 revealed strong increase in expression level in mammalian cells, while preserving the capability of self-assembly into virus-like particles. To gain a sufficient amount of particles for the use in infection studies, further experiments that focus on the optimization of the nuclear import of the 11 L1h protein have to be performed in the future. Nevertheless, the high protein amount expressed from the 11 L1h gene facilitates the analysis of late events following HPV 11 infection in mammalian cells. To this end, our further research will focus on the influence of the major capsid protein on the cellular proteome by using 2D Page and Maldi-TOF mass spectrometry.
Finally, we received promising results in mice immunization experiments by achieving the production of HPV 11 L1-specific antibodies after DNA vaccination using the codon-optimized L1 gene. This induction of significant titers of antibodies may render the 11 L1h gene a useful tool to generate vaccines for the prevention of benign lesions.
Materials and methods
Construction of a codon-modified HPV 11 L1 gene
For engineering of the synthetic, codon-modified HPV 11 L1 gene (11 L1h), 13 pairs of oligonucleotides were synthesized and used in a template-free PCR. The coding region was designed to contain the most frequently used codons found in highly expressed genes in Homo sapiens according to the codon usage table taken from GenBank Database. The sense strand primers started with an added EcoRI restriction site 5V to the initiation codon and continued as contiguous oligonucleotides, terminating 20 bases from the end of the gene. The antisense strand oligonucleotides started with an appended HindIII site 3V of the L1 stop codon and continued as contiguous oligonucleotides, ending 20 bases from the start of the gene. In this manner, the overlapping oligonucleotides acted as primers for the opposite strand. The synthetic gene was generated by two consecutive PCR-reactions. Due to the large size of the L1 sequence, the complete gene was built up of three overlapping fragments, spanning the entire L1 gene and each generated using the following PCR method. To allow high-fidelity amplification, Pwo DNA polymerase (Roche, Mannheim, Germany) was used. The assembly of the oligonucleotides was achieved in a first PCR reaction, by combining equal amounts of each oligonucleotide. In a second PCR, an aliquot of the gene assembly reaction mixture was mixed with the first sense strand and the first antistrand primer of the respective fragment, displaying its start and end, and, thus, allowing the amplification of each fragment. The fragments were isolated from the PCR mixtures by agarose gel electrophoresis, purified with QiaexII (Qiagen, Hilden, Germany). The single fragments were first cloned into the pCR2.1 vector by using the TOPO TA cloning kit (Invitrogen, Karlsruhe, Germany), sequenced, and mutations were removed by site-directed mutagenesis. Finally, the three fragments were digested with appropriate restriction endonucleases, and cloned successively into the multiple cloning site of pBSK+, resulting in the complete optimized 11 L1h gene. The sequence of the complete clone was confirmed by the DKFZ sequence service unit. For expression studies, the 11 L1h gene was cloned into the mammalian expression vectors pcDNA3.1 and pFlag-CMV2.
Cell lines and transfections
Cos-1 (African green monkey kidney cells, ATCC # CRL-1650 ), 293T (Human embryonic kidney cells, ATCC # CRL-11268), and CHO-09 (Chinese hamster ovary cells, kindly provided by J.A. Maassen from the University of Leiden) cells were grown in Dulbecco's modified Eagle's Medium supplemented with 10% heat-inactivated fetal calf serum and 1% penicillin -streptomycin. All cell lines were cultivated in a humidified atmosphere with 5% CO 2 at 37 jC. Transfection was carried out depending on the cell type at 40-90% confluence by using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions or by the calcium phosphate precipitation method.
DNA immunization
Six-week-old female Balb/c mice were used for DNA immunization experiments with Qiagen purified plasmid dissolved in phosphate-buffered saline (PBS) to a final concentration of 1 mg/ml. For each construct, the immunization was carried out twice within 4 weeks by intramuscularly injecting (i.m.) 50 Ag of plasmid into each of the anterior tibialis muscle. Five days before each immunization, mice were treated with Cardiotoxin (0,0625 mg/ ml, Latoxan, New York) to induce a local inflammation. During immunization, mice were anesthetized with Metofane (Janssen-Cilag, Neuss, Germany). After another 2 weeks, mice were sacrificed by cervical dislocation, blood was collected by cardiac puncture, and sera were tested for 11 L1 antibodies in a HPV 11 L1-specific GST-capture ELISA.
ELISA
For the detection of HPV 11 L1-specific antibodies in the sera of the immunized mice, a GST-capture ELISA was performed according to the method of Sehr et al. (2001) . For this purpose, microtiter plates were coated with 200 ng/well of glutathione casein in 50 mM carbonate buffer, pH 9.6, at 4 jC overnight. The next day, the coating buffer was replaced by 180 Al/well blocking buffer (0.2% w/v casein in PBS, 0.05% Tween 20) and incubated 1 h at 37 jC. After removing the blocking buffer, the cleared lysates from E. coli strain BL21 expressing GST-HPV 11 L1 proteins diluted in blocking buffer to a concentration of 0.25 Ag/ Al total lysate protein were added and incubated for 1 h at room temperature. Then, mice sera were diluted 1:50 in blocking buffer containing 0.25 Ag/Al total lysate protein from the parental E. coli-strain BL21 and incubated for 1 h at 4 jC to block reaction of the sera with contaminating E. coli proteins. Coated ELISA plates were then incubated for 1 h with 100 Al/well of diluted and preincubated serum. Bound HPV 11 L1-specific antibodies were detected by goat antimouse IgG/M polyclonal antibody conjugated to HRP (1: 10000 dilution in blocking buffer, incubation for 1 h at room temperature; Dianova, Hamburg, Germany). Then, plates were washed and the color reaction using tetramethylbenzidine (Sigma, Munich, Germany) (10 mg/ml in 0.1 M NaAcetate, pH 6.0, 0.003% H 2 O 2 , 100 Al/well) as substrate was started. After 8 min, the enzyme reaction was stopped by adding 50 Al of 1 M sulfuric acid per well and the absorbance at 450 nm was measured in a automated ELISA plate reader. As a control, sera were tested for binding to GST-HPV-6b L1 and GST HPV 16 L1 proteins produced in E. coli. Readings obtained with GST tag protein were subtracted as background.
Western blot analysis
Cells growing on 10-cm-diameter dish were transfected with 10 Ag of the various plasmids, and allowed to express the protein for 48 h. Then, cells were washed twice with icecold PBS and lysed in 1% sodium dodecyl sulfate (SDS) loading buffer by heating to 95 jC for 5 min.
Protein concentrations were determined using the BioRad detergent compatible kit (Bio-Rad, Munich, Germany) as suggested by the manufacturer. In all cases, 50 Ag of protein were separated on 12.5% polyacrylamide gels by SDS polyacrylamide gel electrophoresis (PAGE), and blotted onto nitrocellulose membranes. The filters were blocked overnight at 4 jC in PBS -0.1% Tween 20 containing 5% skim milk powder (blocking solution) and were then incubated for 1 h at room temperature with the monoclonal antibody CamVir-1 (BD Pharmingen, San Diego, USA; 1:2000 in blocking solution), the polyclonal rabbit anti-Flag antibody (Sigma-Aldrich; diluted 1:1000 in blocking solution), the polyclonal goat anti-Calnexin (Santa Cruz, Heidelberg, Germany; diluted 1:100 in blocking solution), or with the Hybridoma anti-histone H1 antibody (hybridoma cells were kindly provided by S. Khochbin from the University Joseph Fourier, Inserm, Institute Albert-Bonniot, Grenoble), respectively. The membranes were washed 3 times in PBS -0.1% Tween 20 for 5 min and then incubated with a peroxidase-coupled goat anti-mouse or goat antirabbit antibody diluted 1:10,000 in blocking solution for 1 h at room temperature. After being washed, 11 L1 protein was detected using an enhanced chemiluminescence detection kit (Amersham, Braunschweig, Germany).
Indirect immunofluorescence (IIF)
Cells growing on glass cover slips were fixed 48 h after transfection via incubation in À 20 jC methanol (5 min) and acetone (20 s) at 4 jC and then air dried and rehydrated in PBS for 5 min. The cells were incubated with the monoclonal antibody CamVir-1 (BD Pharmingen) diluted 1:20 or the polyclonal anti-Flag antibody (Sigma-Aldrich) diluted 1:160 in PBS containing 0.3% bovine serum albumin for 1 h at room temperature. The cells were then washed 3 times in PBS and incubated with fluorochromeconjugated anti-mouse or anti-rabbit secondary antibody (Mo Bi Tec Göttingen, Germany) diluted 1:100 in PBS containing 1% skim milk powder for 1 h at room temperature. After being washed 3 times in PBS, the slides were embedded in Fluoprep (bioMérieux, Nürtingen, Germany) and analyzed with a confocal laser scanning microscope, Leica TCS SP (Leica, Bensheim, Germany). In case of cell nuclei counterstain, propidium iodide (0.5 mg/ml) was added to the secondary antibody.
Electron microscopy
To visualize VLPs after transient transfection, cells were grown on cover slips, washed with PBS containing 1 mM MgCl 2 , and fixed for 30 min with 2.5% glutaraldehyde (Serva, Heidelberg, Germany) in cacodyle-buffer followed by a second fixation step with osmium tetroxide (Polyscience, Niles, USA). After dehydration with increasing concentrations of ethanol, cells were embedded in epoxide resin. Ultrathin sections (50 nm) of the cells were stained with 1% uranyl acetate and lead citrate. The sections were examined with a Zeiss EM 10A microscope (Zeiss, Oberkochen, Germany).
Subcellular proteome extraction
Cells growing on a six-well-plate were transfected with 2 Ag of the codon-optimized 11 L1-gene. Forty-eight hours after transient transfection, cellular proteins were separated into a cytosolic, a membranous, a nuclear, and a cytoskeletal fraction according to the manufacturer's protocol of the subcellular proteome extraction kit (Calbiochem, Darmstadt, Germany) . Protein concentrations of the above-mentioned fractions were determined by the DC protein Assay (BioRad). One percent of the protein amount of each fraction was analyzed by Western blotting as described above.
Quantitative RT-PCR of L1 mRNA Cells were transiently transfected with either pcDNA3.1, 11 L1wt, or 11 L1h. Forty-eight hours later, total RNA was isolated using the RNeasy Mini Kit (Qiagen). The reverse transcription reaction was carried out using the iScript cDNA synthesis kit (Bio-Rad) containing both oligo (dT) and random hexamer primers. The PCR oligonucleotides for the neomycin gene were S-5V-TGA ATG AAC TGC AGG ACG AG-3V and AS-5V-ATA CTT TCT CGG CAG GAG CA-3V . For the 11 L1wt gene, the primer oligonucleotides were S-5V-GCCATGTGGAGGAGTTTGAT-3Vand AS-5V-AGGTGTGGGTTTCTGACAGG-3V . For the 11 L1h gene, the PCR oligonucleotides were S-5V-AGGT-GATGGCCTACATCCAC-3V and AS-5V-CTGGTTCTG-CCTCTGTAGCC-3V .
Real-time PCR was performed using the iQ SYBR Green Supermix (Bio-Rad) on an iCycler real-time PCR machine (Bio-Rad).
